Development of injectable colloidal solution forming an <i>in situ</i> hydrogel for tumor ablation-Reference-Cited by-同舟云学术

Development of injectable colloidal solution forming an in situ hydrogel for tumor ablation

Published:2024 Issue:17 Volume:12 Page:4483-4492
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Choi Seong Jin¹²,Lee Sanghee¹,Choi Hyunjun¹,Ko Min Jun¹^ORCID,Kim Donghwan²^ORCID,Kim Dong-Hyun¹³⁴⁵^ORCID

Affiliation:

1. Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

2. School of Chemical Engineering, Sungkyunkwan University (SKKU), Suwon 16419, Korea

3. Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA

4. Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, Evanston, IL 60208, USA

5. Department of Biomedical Engineering, University of Illinois, Chicago, IL 60607, USA

Abstract

We developed percutaneous intra-tumoral injectable tumor ablation colloidal solution that can be transformed to an MRI visible hydrogel drug depot in tumor tissues.

Funder

National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

Ministry of Trade, Industry and Energy

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00598H

Reference33 articles.

1. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

2. Epidemiology and Management of Hepatocellular Carcinoma

3. Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment

4. Enhancing Ablation: Synergies with Regional and Systemic Therapies

5. MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial